The FDA just approved Ozempic for kidney disease

Novo Nordisk (NVO) announced today that its blockbuster drug Ozempic was approved by the Food and Drug Administration (FDA) as the first GLP-1 treatment for chronic kidney disease among people with type 2 diabetes.Read more…

About Author

Bruce Gil

See author's posts

The FDA just approved Ozempic for kidney disease

About Author

Bruce Gil

Maternal Sepsis Rates Spiked After Texas Abortion Law in High-Risk Group

Most Ditch GLP-1 Drugs for Weight Loss Within a Year

Family Alleges Cover-Up in Case of Patient Who Died After Having His Liver Removed

Maternal Sepsis Rates Spiked After Texas Abortion Law in High-Risk Group

Most Ditch GLP-1 Drugs for Weight Loss Within a Year

Family Alleges Cover-Up in Case of Patient Who Died After Having His Liver Removed

Some Hospitals Pause Gender-Affirming Care to Evaluate Trump’s Executive Order

When Grandma Falls in Love

Should RSV Vaccination Expand to Younger High-Risk Groups?

Medical Education Needs Its Own AI Playbook

Te Whatu Ora proposes to ax a third of data, digital roles

FDA issues warning letters to three foreign seafood companies for HACCP Violations

EU countries highlight foodborne illness investigations

Maternal Sepsis Rates Spiked After Texas Abortion Law in High-Risk Group

Most Ditch GLP-1 Drugs for Weight Loss Within a Year

Family Alleges Cover-Up in Case of Patient Who Died After Having His Liver Removed

Some Hospitals Pause Gender-Affirming Care to Evaluate Trump’s Executive Order

When Grandma Falls in Love

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories